Loading
Latest filing published 20 Sept 2026 for Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp., €37k.
No signal scores available.
Michelle Seltenrich appears in our data through filings on Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. shares, published by SEDI. In total, 3 filings cover trades dated from 15 March 2026 to 16 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 20 September 2026, reports an option exercise of €37k in Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations